Welcome to Aston Particle Technologies Ltd

Aston Particle Technologies is a spin-out from the School of Pharmacy at Aston University. The company was formed in 2016 and has secured seed investment alongside an InnovateUK grant.


What we do

Aston Particle Technologies are commercialising its Novel Isothermal Dry Particle Coating technique (iDPC), which processes drugs without the use of solvents or heat. iDPC's USP lies in delivering enhanced particle properties, particularly for challenging drugs (high dose, moisture or heat sensitive) without compromising their innate properties. iDPC offers multiple benefits in the formulation of Dry Powder Inhalers (DPIs), including manufacture of high dose DPI's as well the formulation of Oral Solid Dosage Forms (OSD's).
The technology is IP protected (WO 2016/066462 A1).


Isothermal Dry Particle Coating (iDPC)

iDPC involves the adsorption/adherence of fine "guest" particles onto the surface of coarse "carrier" particles leading to enhanced functionality, stability and product performance.

Why Choose APT

iDPC is the first dry particle coating manufacturing technique for the pharmaceutical sector that will deliver multiple benefits including:

  • One-step, cost effective and high yield (>95%) production process
  • No particle attrition or fracture
  • No use/generation of heat with no solvent use
  • No contamination / no oxidation or interaction between components